X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5257) 5257
Newsletter (10) 10
Magazine Article (9) 9
Book Chapter (6) 6
Dissertation (3) 3
Book / eBook (2) 2
Conference Proceeding (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3878) 3878
photodynamic therapy (2627) 2627
photochemotherapy (2489) 2489
photosensitizing agents - administration & dosage (2409) 2409
animals (1998) 1998
female (1976) 1976
photochemotherapy - methods (1947) 1947
photosensitizing agents - therapeutic use (1847) 1847
male (1794) 1794
cancer (1756) 1756
photosensitizing agents - pharmacology (1154) 1154
treatment outcome (1126) 1126
mice (1063) 1063
middle aged (1036) 1036
oncology (915) 915
adult (878) 878
aged (871) 871
cell line, tumor (822) 822
5-aminolevulinic acid (812) 812
dermatology (760) 760
light (758) 758
photosensitizing agents - chemistry (747) 747
aminolevulinic acid - administration & dosage (742) 742
fluorescence (666) 666
surgery (663) 663
biochemistry & molecular biology (617) 617
photosensitizing agents - pharmacokinetics (585) 585
care and treatment (576) 576
tumors (521) 521
biophysics (501) 501
ophthalmology (496) 496
pharmacology & pharmacy (479) 479
in-vitro (468) 468
therapy (462) 462
nanoparticles (460) 460
internal medicine (452) 452
aminolevulinic acid - therapeutic use (443) 443
cell survival - drug effects (440) 440
aged, 80 and over (438) 438
hematology, oncology and palliative medicine (427) 427
dose-response relationship, drug (422) 422
apoptosis (417) 417
analysis (411) 411
porphyrins - therapeutic use (407) 407
porphyrins - administration & dosage (406) 406
photosensitizing agents - adverse effects (399) 399
lasers (386) 386
administration, topical (379) 379
time factors (370) 370
photosensitizer (367) 367
rats (367) 367
in-vivo (359) 359
photosensitizers (359) 359
skin (353) 353
cells (349) 349
follow-up studies (339) 339
skin neoplasms - drug therapy (330) 330
aminolevulinic acid - analogs & derivatives (329) 329
photochemotherapy - adverse effects (319) 319
health aspects (317) 317
chemistry, multidisciplinary (316) 316
drug delivery systems (315) 315
mice, inbred balb c (315) 315
mice, nude (295) 295
neoplasms - drug therapy (295) 295
apoptosis - drug effects (288) 288
delivery (278) 278
aminolevulinic acid (274) 274
ultraviolet rays (273) 273
singlet oxygen (272) 272
prospective studies (269) 269
porphyrins (265) 265
research (264) 264
verteporfin (260) 260
medicine & public health (248) 248
tumor (248) 248
combined modality therapy (245) 245
disease models, animal (244) 244
aminolevulinic acid - pharmacology (243) 243
carcinoma (237) 237
photosensitizing agents (235) 235
adolescent (234) 234
efficacy (233) 233
drug-delivery (232) 232
pdt (225) 225
retrospective studies (225) 225
nanoparticles - chemistry (223) 223
porphyrins - pharmacology (222) 222
liposomes (212) 212
fluorescein angiography (209) 209
macular degeneration (207) 207
nanoscience & nanotechnology (206) 206
young adult (206) 206
protoporphyrin ix (205) 205
tissue distribution (205) 205
chemotherapy (203) 203
antineoplastic agents - administration & dosage (201) 201
porphyrins - chemistry (199) 199
administration, cutaneous (198) 198
reactive oxygen species - metabolism (197) 197
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5143) 5143
German (49) 49
Russian (35) 35
Japanese (28) 28
French (19) 19
Chinese (14) 14
Spanish (11) 11
Polish (6) 6
Korean (4) 4
Portuguese (3) 3
Czech (2) 2
Danish (2) 2
Hebrew (2) 2
Hungarian (2) 2
Dutch (1) 1
Finnish (1) 1
Lithuanian (1) 1
Norwegian (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


ACS Nano, ISSN 1936-0851, 02/2017, Volume 11, Issue 2, pp. 2227 - 2238
Poor tumor penetration is a major challenge for the use of nanoparticles in anticancer therapy. Moreover, the inability to reach hypoxic tumor cells that are... 
hypoxia | cancer | nanoparticles | tumor penetration | iRGD | photodynamic therapy | DRUG-DELIVERY | COMBINATION THERAPY | MATERIALS SCIENCE, MULTIDISCIPLINARY | TISSUE | CHEMISTRY, PHYSICAL | TIRAPAZAMINE | NANOSCIENCE & NANOTECHNOLOGY | CHEMISTRY, MULTIDISCIPLINARY | CANCER-THERAPY | PEPTIDE | BREAST-CANCER | MICROENVIRONMENT | EFFICIENT | POLYMER HYBRID NANOPARTICLES | Prodrugs - administration & dosage | Hypoxia - drug therapy | Injections, Intravenous | Photosensitizing Agents - chemistry | Reactive Oxygen Species - metabolism | Nanoparticles - chemistry | Apoptosis - drug effects | Prodrugs - chemistry | Antineoplastic Agents - administration & dosage | Indocyanine Green - pharmacology | Photochemotherapy | Drug Delivery Systems | Tirapazamine - chemistry | Photosensitizing Agents - administration & dosage | Tissue Distribution | Indocyanine Green - chemistry | Photosensitizing Agents - pharmacology | Antineoplastic Agents - pharmacology | Molecular Structure | Tumor Cells, Cultured | Indocyanine Green - administration & dosage | Tirapazamine - administration & dosage | Tirapazamine - pharmacology | Antineoplastic Agents - chemistry | Reactive Oxygen Species - analysis | Animals | Cell Proliferation - drug effects | Mice | Nanoparticles - administration & dosage | Prodrugs - pharmacology | Drug Screening Assays, Antitumor | Nanoparticles | Drugs | Therapy | Drug delivery systems | Photodynamic therapy | Penetration | Tumors | Anticancer properties | Hypoxia | Tumor Penetration | Photodynamic Therapy | Cancer
Journal Article
Chemical Communications: Chem Comm, ISSN 1359-7345, 4/2014, Volume 5, Issue 36, pp. 4659 - 4673
.... In particular, we highlight the use of metabolic oligosaccharide engineering to covalently deliver therapeutics and imaging agents to bacterial glycans... 
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 06/2016, Volume 232, pp. 1 - 8
Near infrared photoimmunotherapy (NIR-PIT), a targeted cancer therapy which uses an antibody-photo absorber conjugate (APC) and near infrared light exposure,... 
Photoimmunotherapy | Drug delivery | Near infrared light | Enhanced permeability and retention effect | Micro distribution | CANCER-CELLS | CHEMOSENSITIVITY | METASTASIS | PHOTODYNAMIC THERAPY | MOUSE | TUMOR | CHEMISTRY, MULTIDISCIPLINARY | DELIVERY | ENHANCED PERMEABILITY | IN-VIVO | PHARMACOLOGY & PHARMACY | CYCLE | Carbocyanines - chemistry | Photosensitizing Agents - chemistry | Cetuximab - chemistry | Photosensitizing Agents - therapeutic use | Carbocyanines - administration & dosage | Humans | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Cetuximab - therapeutic use | Photochemotherapy | Photosensitizing Agents - administration & dosage | Neoplasms - therapy | Immunotherapy | Light | Female | Trastuzumab - chemistry | Trastuzumab - therapeutic use | Organophosphorus Compounds - therapeutic use | Organophosphorus Compounds - chemistry | Trastuzumab - administration & dosage | Carbocyanines - therapeutic use | Antineoplastic Agents - chemistry | Xenograft Model Antitumor Assays | Animals | Mice, Nude | Cell Line, Tumor | Cetuximab - administration & dosage | Organophosphorus Compounds - administration & dosage | Microscopy, Fluorescence | Drugs | Viral antibodies | Drug delivery systems | Fluorescence | Antibodies | Permeability | Fluorescence microscopy | Vehicles | Light-emitting diodes | Antineoplastic agents | Antimitotic agents | Cancer | Tumors | micro distribution | drug delivery | photoimmunotherapy | enhanced permeability and retention effect | near infrared light
Journal Article
Journal Article
Journal Article
Acta Biomaterialia, ISSN 1742-7061, 04/2017, Volume 53, pp. 399 - 413
[Display omitted] Cancer treatments that use a combination of approaches with the ability to affect multiple disease pathways have proven highly effective. The... 
Photothermal antitumor | Nanostructured lipid carrier | IR780 | AMD3100 | Anti-metastatic | MATERIALS SCIENCE, BIOMATERIALS | METASTASIS | PHOTODYNAMIC THERAPY | DRUG-DELIVERY | ENGINEERING, BIOMEDICAL | NANOPARTICLES SLN | CXCR4 | IN-VITRO | INVASION | GROWTH | AGENTS | CELL | Delayed-Action Preparations - radiation effects | Breast Neoplasms - secondary | Photosensitizing Agents - chemistry | Nanocapsules - administration & dosage | Photochemotherapy - methods | Delayed-Action Preparations - chemistry | Antineoplastic Agents - administration & dosage | Nanocapsules - chemistry | Indoles - administration & dosage | Delayed-Action Preparations - administration & dosage | Photosensitizing Agents - administration & dosage | Lipids - chemistry | Liposomes - radiation effects | Female | Lipids - radiation effects | Heterocyclic Compounds - administration & dosage | Treatment Outcome | Lymphatic Metastasis | Breast Neoplasms - drug therapy | Particle Size | Liposomes - chemistry | Animals | Cell Line, Tumor | Breast Neoplasms - diagnosis | Combined Modality Therapy - methods | Mice | Mice, Inbred BALB C | Nanocapsules - radiation effects | Indoles - chemistry | Antimitotic agents | Care and treatment | Breast cancer | Metastasis | Drug therapy | Antineoplastic agents | Cancer | Prevention | Drugs | Drug delivery systems | Vehicles
Journal Article